title: Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D.
authors.forename: T W
authors.initials: TW
authors.lastname: Lavender
authors.forename: A R
authors.initials: AR
authors.lastname: Martineau
authors.forename: R
authors.initials: R
authors.lastname: Quinton
authors.forename: U
authors.initials: U
authors.lastname: Schwab
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002112:Calcifediol / Q000097:blood; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood; D002762:Cholecalciferol / Q000009:adverse effects*; D019587:Dietary Supplements / Q000009:adverse effects*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014396:Tuberculosis, Pleural / Q000150:complications* / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy; D014808:Vitamin D Deficiency / Q000097:blood / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000995:Antitubercular Agents; D015415:Biomarkers; D005938:Glucocorticoids; D002762:Cholecalciferol; D011239:Prednisolone; D002117:Calcitriol; D002112:Calcifediol; D002118:Calcium